Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-centre, Randomised, Open-label, Home Use, Parallel Group, Clinical Investigation of Topically-applied MED3000 Gel and Oral Tadalafil (5 mg) Tablets for the Treatment of Erectile Dysfunction (ED) Over a 24 Week Period

NCT04984993 is registered in ClinicalTrials.gov with Futura Medical Developments Ltd. as lead sponsor.

NCT NCT04984993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04984993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-centre, Randomised, Open-label, Home Use, Parallel Group, Clinical Investigation of Topically-applied MED3000 Gel and Oral Tadalafil (5 mg) Tablets for the Treatment of Erectile Dysfunction (ED) Over a 24 Week Period
Lead sponsor
Futura Medical Developments Ltd.
Phase
Phase 3
Overall status
Completed
Start date
September 14, 2021
Completion date
July 13, 2022
Enrollment
116 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction